Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of PF-07921585 alone or with other anti-cancer medicines in multiple cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• PF-07921585

Snippet

Sponsor: Pfizer | Conditions: Non Small Cell Lung Cancer, Bladder Cancer | Phase 1 | Status: TERMINATED